Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05439928 · ClinicalTrials.gov registry record · NA
Remote Glucose Monitoring System in Hospitalized Patients With Diabetic Ketoacidosis (DKA)
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 163
- Enrollment target
NCT05439928 is a NA study that has completed, run by Columbia University. The registered enrollment target is 163 participants.
The verdict
NCT05439928, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 163 participants
- Enrollment target
Study Summary
The purpose of this research study is to investigate the use of continuous glucose monitoring (CGM) device DEXCOM G6 in non-critically patients treated for diabetic emergency such as diabetic ketoacidosis (DKA). Patients who have DKA require hourly monitoring of glucose (sugar) level which traditionally requires admission to the intensive care unit (ICU) for hourly fingerstick monitoring. With the use of CGM device, in this research study hourly fingerstick monitoring is replaced by continuous glucose monitor (CGM) which provides glucose levels continuously in real time for nurses and provider. The investigators are testing to see if in the future patients can be treated in the stepdown unit (an intermediate care level between the intensive care unit and the general medical unit) if they do not require higher level of care besides hourly glucose monitoring. Continuous glucose monitoring (CGM) device DEXCOM G6 currently FDA Approved for patients with diabetes and is widely used for glucose monitoring in patients with diabetes in the outpatient setting. The investigators want to study the use of the DEXCOM G6 CGM in the inpatient setting to monitoring glucose levels remotely in the treatment of diabetic emergencies such as diabetic ketoacidosis and compare their care to those receiving hourly fingerstick glucose monitoring in the ICU.
Interventions
- DEVICE DEXCOM G6 CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2022-06-07 |
| Est. Completion | 2023-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05439928
The ClinicalTrials.gov registry entry for NCT05439928 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DEXCOM G6 CGM is the first listed.
NCT05439928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05439928 about?
NCT05439928 is a clinical study titled "Remote Glucose Monitoring System in Hospitalized Patients With Diabetic Ketoacidosis (DKA)". The purpose of this research study is to investigate the use of continuous glucose monitoring (CGM) device DEXCOM G6 in non-critically patients treated for diabetic emergency such as diabetic ketoacidosis (DKA). Patients who have DKA require hourly monitoring of glucose (sugar) level which tradition...
What is the current status of trial NCT05439928?
This trial is currently completed. It is a NA study. The enrollment target is 163 participants. The study started on 2022-06-07. Estimated completion is 2023-03-31.
What interventions are being tested in trial NCT05439928?
The interventions under investigation include: DEXCOM G6 CGM (DEVICE).
Who is sponsoring clinical trial NCT05439928?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.